Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players√Ę‚ā¨‚ĄĘ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Interleukin-10 (IL-10)-Pipeline Market Review Information, by product (AM-0010, ANV-103, AS-101, BT-063, DEKAVIL / F8 IL10, EG-12, LEO-32731, MK-1966, PD-2244, XT-101, XT-150, therapies and others)


ID: MRFR/Pharma/1971-HCR | 110 Pages | Author: Kinjoll Dey| April 2024

Interleukin-10 (IL-10) - Pipeline Market Overview:


The Interleukin-10 (IL-10)-Pipeline market is projected to reach USD 30.06 billion by 2032 at 15.5% CAGR during the forecast period 2023-2032.


Interleukin-10 is an anti-inflammatory cytokines. Interleukin 10 helps to reduce the inflammation of immune cells by blocking the production of cytokines. They help to reduce the inflammation of immune cells by blocking the production of cytokines. Interleukin 10 (IL10) pipeline targets close to 2o molecules which are developed by Companies and the Universities/Institutes. The molecules developed by Companies in Phase II, Phase I and Preclinical stages are 4, 2 and 9 respectively.  


Interleukin-10 (IL-10) ‚Äď Pipeline, By Stage of Development:


 Interleukin Market iamge


Study Objectives Interleukin-10 (IL-10) - Pipeline Review:



  • It provides a snapshot of the global therapeutic landscape for Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10)

  • It reviews Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • It features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

  • The key players involved in Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics and enlists all their major and minor projects

  • The report assesses Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

  • The report reviews latest news and deals related to Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics.


Intended Audience



  • Companies with Interleukin-10 products

  • Government Research Laboratories

  • Academic Universities/Institutes

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories


Key Finding



  • The Interleukin-10 (IL-10) - Pipeline Review 18 products are in pipeline

  • 9 products are in preclinical trials, 4 in phase II, 2 in phase I and 2 studies are discontinued due to tolerance issues


Key Players for Interleukin-10 (IL-10) - Pipeline Review:


Some of the key players in this market are: Pfizer Inc., Merck & Co., Inc, Biotest AG, BioMAS Ltd, EnGene Inc., Leo Pharma, Anvil Biosciences, Intrexon Corporation, P2D Biosciences, Xalud Therapeutics INC and others.


Interleukin-10 (IL-10) - Pipeline Market Segment Insights:


Interleukin-10 (IL-10) - Pipeline Review report has been segmented on the basis of product type which comprises of AM-0010, ANV-103, AS-101, BT-063, DEKAVIL / F8 IL10, EG-12, LEO-32731, MK-1966, PD-2244, XT-101, XT-150, therapies and others


The report for Interleukin-10 (IL-10) - Pipeline Review of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Report Attribute/Metric Details
  Market Size 30.06 Billion
  CAGR   15.5%
  Base Year   2021
  Forecast Period   2023-2032
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   product
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Pfizer Inc., Merck & Co., Inc, Biotest AG, BioMAS Ltd, EnGene Inc., Leo Pharma, Anvil Biosciences, Intrexon Corporation, P2D Biosciences, Xalud Therapeutics INC
  Key Market Opportunities   Joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments
  Key Market Drivers    technological advancement, macro economical and governing factors


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization